Morgen Eric has filed 7 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 110000 shares of BioAge Labs, Inc. ($BIOA) on February 17, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | BioAge Labs, Inc. | $BIOA | Morgen Eric | Chief Operating Officer | A | Stock Option (Right to Buy) | 110000 | $0.00 | 122,500.0000 | 35,855,037 | 880.00% | 0.31% |
| Feb. 17, 2026 | BioAge Labs, Inc. | $BIOA | Morgen Eric | Chief Operating Officer | A | Stock Option (Right to Buy) | 12500 | $0.00 | 122,500.0000 | 35,855,037 | 11.36% | 0.03% |
| Feb. 18, 2025 | BioAge Labs, Inc. | $BIOA | Morgen Eric | Chief Operating Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 18, 2025 | BioAge Labs, Inc. | $BIOA | Morgen Eric | Chief Operating Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| April 17, 2024 | BioAge Labs, Inc. | $BIOA | Morgen Eric | Chief Operating Officer | A | Stock Option (Right to Buy) | 13598 | $0.00 | 271,571.0000 | 0 | 5.27% | 0.00% |
| Sept. 25, 2024 | BioAge Labs, Inc. | $BIOA | Morgen Eric | Chief Operating Officer | A | Stock Option (Right to Buy) | 4952 | $0.00 | 262,925.0000 | 0 | 1.92% | 0.00% |
| April 17, 2024 | BioAge Labs, Inc. | $BIOA | Morgen Eric | Chief Operating Officer | A | Stock Option (Right to Buy) | 257973 | $0.00 | 271,571.0000 | 0 | 1897.14% | 0.00% |